Risks of Accelerated Opioid Use in Patients with Kidney Stones

Medication Concerns with Accelerated Use

Accelerated use of Norco increases the risk of respiratory depression, particularly in patients with renal impairment where drug clearance may be reduced, according to the Journal of Clinical Oncology 1
Higher doses of Norco taken over shorter periods increase the risk of central nervous system depression, as reported by the Journal of Clinical Oncology 1

Topiramate, which is sometimes used for pain management, should be avoided in patients with a history of kidney stones, as stated in Gastroenterology 2
Kidney stones and associated renal impairment can reduce drug clearance, leading to accumulation of hydrocodone and acetaminophen metabolites, according to the American Journal of Kidney Diseases 3

Evaluate for signs of toxicity, including respiratory depression, excessive sedation, and liver or kidney dysfunction, as recommended by MMWR Recommendations and Reports 4
Assess renal function to determine the extent of impairment, as suggested by the American Journal of Kidney Diseases 3

Consider opioid rotation to opioids with less risk of metabolite accumulation in patients with significant renal impairment, as advised by the Journal of Clinical Oncology 1
Avoid morphine, codeine, and tramadol in patients with renal impairment due to accumulation of neurotoxic metabolites, as recommended by the Journal of Clinical Oncology and the Journal of the National Comprehensive Cancer Network 1, 5
Consider fentanyl or hydromorphone as safer alternatives in patients with renal impairment when carefully titrated, as suggested by the Journal of Clinical Oncology and the Journal of the National Comprehensive Cancer Network 1, 5

Patients with renal impairment who receive opioids should have more frequent monitoring and dose adjustments, as recommended by the Journal of Clinical Oncology 1
Monitor for signs of addiction, as accelerated use may indicate development of tolerance, dependence, or addiction, according to MMWR Recommendations and Reports 4
Educate patients on the importance of taking medications as prescribed, especially in the context of renal impairment, as advised by MMWR Recommendations and Reports 4
Consider naloxone prescription for patients taking high doses of opioids, especially with concomitant risk factors, as recommended by the Journal of Clinical Oncology 1

Avoid NSAIDs in severe renal impairment, as they should be avoided in patients with GFR < 30 ml/min/1.73 m², according to the American Journal of Kidney Diseases 3
Beware of drug interactions, as multiple medications commonly used in kidney stone patients may interact with opioids, increasing toxicity risk, as reported by the American Journal of Kidney Diseases 3
Monitor for urinary retention, as opioids can cause urinary retention, which may complicate kidney stone passage, as advised by the Journal of Clinical Oncology 1
Avoid rapid dose escalation, as rapid increases in opioid dosage put patients at greater risk for sedation, respiratory depression, and overdose, according to MMWR Recommendations and Reports 4